The NCIC Clinical Trials Group / Intergroup / NCIC CTG Central / /
Country
United States / /
Event
FDA Phase / Person Communication and Meetings / /
Facility
National Cancer Institute / Regulatory Affairs Group Investigational New Drug NCIC Clinical Trials Group National Cancer Institute / /
IndustryTerm
therapy of cancer / travel costs / Cancer Therapy / study protocol / trial protocol / cooperative / pharmaceutical / web- based document / web-based materials / applicable pharmaceutical / prevention of cancer / regulatory agency communications / /
MedicalCondition
cancer / disease / /
MedicalTreatment
radiation / /
Movie
Conflict of Interest 5 / /
Organization
National Cancer Institute / Cooperative Group Data Monitoring Committee / Compliance and Oversight Office / Research Ethics Board / Data Safety Monitoring Committee / Central Office / NCIC CTG Central Office / Clinical Trials Committee / Trial Committee / /
Position
Investigator / The Study Chair / CTEP representative / Director roles / Study Chair of the Trial Committee / Study Chair / Physician Coordinator / Chair and the Director / member for these trials / Physician Coordinator / Deputy Director / Director / Director and the Chair / trial statistician / Physician Coordinator / Statistician and Study Coordinator / Chair / representative / Study Chair / Trial Statistician / Study Chair / /
Product
New Drug / JAN-08 / /
Technology
study protocol / radiation / trial protocol / treating cancer / /
NCIC Clinical Trials Group Policies for the Data Safety Monitoring Committee V002 January 8, 2013 Policies for the Data Safety Monitoring Committee